InsiderClue
← All stocks

Avantor, Inc.

AVTR Net selling
CIK 0001722482 #954 in the set updated 17 Sep 2026
Bought (120 mo)
$27.75M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.21B
$621.18K on a plan · $74.74M straight out of an exercise
Sold at will
$3.14B
106 of 150 sales
Net
−$3.19B
−$3.11B against sales at will

By person

48 insiders · 221 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
New Mountain Investments III, LLC entity
10% owner
—
$1.72B (4)
−$1.72B
28,000,000
4.14%
$232.96M
−74.7%
Natauri Jo
Director
$5.25M (16)
$604.43M (18)
−$599.18M
650,317
0.0961%
$5.41M
—
GOLDMAN SACHS & CO. LLC entity
10% owner
$5.24M (15)
$523.85M (17)
−$518.60M
43,483,708
6.43%
$361.78M
+1,595,632%
Connolly Thomas
Director
$5.24M (15)
$223.50M (16)
−$218.26M
58,881,710
8.71%
$489.90M
+1,581,891%
GUPTA RAJIV
Director
—
$40.17M (10)
−$40.17M
1,058,671
0.1565%
$8.81M
+138.1%
Stubblefield Michael
President & CEO
$314.25K (1)
$35.52M (7) scheduled
−$35.20M
1,764,513
0.2609%
$14.68M
—
Brophy Gerard
EVP, Biopharma Production
—
$22.19M (17) scheduled
−$22.19M
89,032
0.0132%
$740.75K
—
Ohri Devashish
EVP, IMEA
—
$14.51M (13) scheduled
−$14.51M
139,095
0.0206%
$1.16M
—
Vanderhaegen Frederic
EVP, Americas and Europe
—
$8.31M (7)
−$8.31M
160,735
0.0238%
$1.34M
+5,380%
Couturier Christophe
EVP, AMEA
—
$6.71M (14) scheduled
−$6.71M
211,271
0.0312%
$1.76M
+3,758%
MEHRA SANJEEV K
Director
$4.88M (2)
—
+$4.88M
508,376
0.0752%
$4.23M
—
SUMME GREGORY L
Director
$4.56M (7)
—
+$4.56M
483,381
0.0715%
$4.02M
—
Miller Justin
EVP & General Counsel
—
$4.47M (4) scheduled
−$4.47M
93,336
0.0138%
$776.56K
+3,290%
Wondrasch Michael
EVP & CIO
—
$2.55M (5) scheduled
−$2.55M
96,072
0.0142%
$799.32K
—
Bramwell James
EVP Sales, Customer Excellence
—
$1.66M (10)
−$1.66M
86,605
0.0128%
$720.55K
+754.3%
Eck Steven W
SVP & Chief Accounting Officer
—
$1.18M (7)
−$1.18M
129,593
0.0192%
$1.08M
+592.0%
Ligner Emmanuel
President and CEO
$993.13K (1)
—
+$993.13K
737,334
0.1090%
$6.13M
—
LUCIER GREGORY T
Director
$541.20K (2)
—
+$541.20K
94,006
0.0139%
$782.13K
—
Shaw Christi
Director
—
$381.15K (1)
−$381.15K
36,271
0.0054%
$301.77K
—
Szlosek Thomas A
EVP & CFO
$258.85K (1)
—
+$258.85K
113,157
0.0167%
$941.47K
—
Dingemans Simon
Director
$203.50K (1)
—
+$203.50K
56,495
0.0084%
$470.04K
—
Peacock Jonathan M
Director
$103.65K (1)
—
+$103.65K
219,815
0.0325%
$1.83M
+1,140%
Massaro Joseph R
Director
$99.63K (1)
—
+$99.63K
77,408
0.0114%
$644.03K
—
Kang Lan
Director
$62.85K (1)
—
+$62.85K
52,315
0.0077%
$435.26K
—
Jones R. Brent
EVP, Chief Financial Officer
—
—
—
419,782
0.0621%
$3.49M
+18,328%
Walker Corey
President, VWR Dist. & Servs.
—
—
—
384,535
0.0569%
$3.20M
—
Gourdier Benoit
EVP, Bioscience & Medtech
—
—
—
362,859
0.0536%
$3.02M
—
Blenn Mary
EVP, Chief Operating Officer
—
—
—
253,384
0.0375%
$2.11M
—
Sokenu Claudius
EVP, Chief Legal & Compliance
—
—
—
251,228
0.0371%
$2.09M
—
Hankamer Brittany
EVP, Chief HR Officer
—
—
—
248,864
0.0368%
$2.07M
+876.0%
McAllister Eric
EVP, CHRO
—
—
—
197,899
0.0293%
$1.65M
+180.8%
Hofman Bjorn
EVP and COO
—
—
—
157,143
0.0232%
$1.31M
—
Brellier Ludovic
EVP, Bioscience & Medtech
—
—
—
146,566
0.0217%
$1.22M
—
Kulkarni Ashish
See Remarks
—
—
—
128,571
0.0190%
$1.07M
—
SEVERINO MICHAEL
Director
—
—
—
85,821
0.0127%
$714.03K
—
Lewis Sheri
EVP, Global Ops & Supply Chain
—
—
—
70,692
0.0105%
$588.16K
+2,356,300%
Murthy Mala
Director
—
—
—
69,479
0.0103%
$578.07K
—
Stone Randy Lee
EVP, Laboratory Solutions
—
—
—
68,105
0.0101%
$566.63K
+7,746%
Andres Juan
Director
—
—
—
65,480
0.0097%
$544.79K
+1,703%
Makin Louise
Director
—
—
—
47,140
0.0070%
$392.20K
—
Carethers John
Director
—
—
—
45,858
0.0068%
$381.54K
—
Sahin Kitty
EVP, Strategy&Corp Development
—
—
—
42,274
0.0063%
$351.72K
+58.4%
Henson Meghan
EVP, Chief HR Officer
—
—
—
40,184
0.0059%
$334.33K
—
Foxe Tanya
EVP, Operations & Supply Chain
—
—
—
39,458
0.0058%
$328.29K
—
SACHDEV RAKESH
Director
—
—
—
32,841
0.0049%
$273.24K
—
Henrichwark Sven
EVP, APAC Region
—
—
—
19,802
0.0029%
$164.75K
—
Murray Mark Christopher
EVP, Biomaterials & AT
—
—
—
18,680
0.0028%
$155.42K
—
Holt Matthew S.
Director
—
—
—
7,908
0.0012%
$65.79K
—

Individual transactions

35
Insider
Date
Role
Action
Shares
Price
Amount
Brophy Gerard
3 Jan 2022
EVP, Biopharma Production
Sold after exercise
59,418
$40.77
$2.42M
Couturier Christophe
27 Dec 2021
EVP, AMEA
Sold after exercise
10,184
$41.63
$423.96K
Couturier Christophe
22 Dec 2021
EVP, AMEA
Sold after exercise
28,125
$41.53
$1.17M
Couturier Christophe
21 Dec 2021
EVP, AMEA
Sold after exercise
38,309
$41.00
$1.57M
Couturier Christophe
9 Dec 2021
EVP, AMEA
Sold after exercise
7,859
$40.24
$316.25K
Couturier Christophe
8 Dec 2021
EVP, AMEA
Sold after exercise
5,828
$40.00
$233.12K
Vanderhaegen Frederic
12 Nov 2021
EVP, Europe
Sold after exercise
80,000
$38.25
$3.06M
Brophy Gerard
30 Jul 2021
EVP, Biopharma Production
Sold after exercise
81,125
$37.24
$3.02M
Stubblefield Michael
10 Jun 2021
President and CEO
Sold after exercise
57,375
$32.48
$1.86M
Stubblefield Michael
10 Jun 2021
President and CEO
Sold after exercise
42,512
$32.48
$1.38M
Stubblefield Michael
9 Jun 2021
President and CEO
Sold after exercise
235,170
$32.03
$7.53M
Stubblefield Michael
8 Jun 2021
President and CEO
Sold after exercise
152,643
$32.04
$4.89M
Ohri Devashish
27 May 2021
EVP, IMEA
Sold after exercise
100,000
$31.99
$3.20M
Ohri Devashish
26 May 2021
EVP, IMEA
Sold after exercise
15,000
$31.87
$478.05K
Ohri Devashish
24 May 2021
EVP, IMEA
Sold after exercise
9,124
$31.75
$289.69K
Ohri Devashish
30 Apr 2021
EVP, IMEA
Sold after exercise
53,649
$32.58
$1.75M
Miller Justin
12 Apr 2021
EVP & General Counsel
Sold after exercise
100,000
$33.21
$3.32M
Miller Justin
12 Apr 2021
EVP & General Counsel
Sold after exercise
2,895
$31.75
$91.92K
Ohri Devashish
12 Apr 2021
EVP, IMEA
Sold after exercise
100,160
$32.37
$3.24M
Brophy Gerard
22 Feb 2021
EVP, Biopharma Production
Sold after exercise
19,769
$28.62
$565.79K
Wondrasch Michael
5 Feb 2021
EVP & CIO
Sold after exercise
40,000
$29.77
$1.19M
Wondrasch Michael
5 Feb 2021
EVP & CIO
Sold after exercise
9,468
$29.77
$281.86K
Brophy Gerard
11 Jan 2021
EVP, Biopharma Production
Sold after exercise
162,248
$30.04
$4.87M
Brophy Gerard
11 Jan 2021
EVP, Biopharma Production
Sold after exercise
216,332
$30.08
$6.51M
Brophy Gerard
4 Jan 2021
EVP, Biopharma Production
Sold after exercise
59,418
$27.84
$1.65M
Stubblefield Michael
7 Dec 2020
President and CEO
Sold after exercise
98,452
$27.45
$2.70M
Stubblefield Michael
4 Dec 2020
President and CEO
Sold after exercise
412,188
$27.08
$11.16M
Ohri Devashish
5 Oct 2020
EVP, IMEA
Sold after exercise
50,000
$23.34
$1.17M
Ohri Devashish
5 Oct 2020
EVP, IMEA
Sold after exercise
35,000
$23.47
$821.45K
Ohri Devashish
5 Oct 2020
EVP, IMEA
Sold after exercise
18,440
$23.53
$433.89K
Ohri Devashish
16 Sep 2020
EVP, IMEA
Sold after exercise
35,000
$23.02
$805.70K
Ohri Devashish
30 Jul 2020
EVP, IMEA
Sold after exercise
35,000
$21.37
$747.95K
Ohri Devashish
29 May 2020
EVP, IMEA
Sold after exercise
35,000
$19.07
$667.45K
Ohri Devashish
29 May 2020
EVP, IMEA
Sold after exercise
30,000
$18.57
$557.10K
Ohri Devashish
18 Feb 2020
EVP, IMEA
Sold after exercise
20,000
$17.54
$350.80K
Show all 221 transactions →

What was left out

Form 4 filings counted 434
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 35
Sales at will 106
Transactions with no price 0
Shares from compensation/vesting 259,237,468
Sales filed before the plan box existed 100
History held since 23 May 2019